Modeling of human CCR5 as Target for HIV-I and Virtual Screening with Marine Therapeutic compounds

Marine derivatives are of great pharmaceutical interest as inhibitory compound and search of bioactive compounds from Marine organism which is relatively new to medicinal chemistry. Our main aim in the study is to screen possible inhibitors against CCR5 which acts as co-receptor M-tropic HIV-1, through virtual screening of 122 Marine derived compounds from various organisms known to have biological activity. Homology Model of CCR5 was constructed using MODELLER and the Model was energy minimized and validated using PROCHECK to obtain a stable structure, which was further used for virtual screening of Marine derived compounds through molecular Docking studies using GOLD. The Docked complexes were validated and Enumerated based on the GOLD Scoring function to pick out the best Marine inhibitor based on GOLD score. Thus from the entire 122 Marine compounds which were Docked, we got best 4 of them with optimal GOLD Score. (LAMIVUDINE: 45.0218, BATZELLINE-D: 44.3852.ACYCLOVIR: 43.1362 and THIIOACETAMIDE: 42.7412) Further the Complexes were analyzed through LIGPLOT for their interaction for the 4 best docked Marine compounds. Thus from the Complex scoring and binding ability its deciphered that these Marine compounds could be promising inhibitors for M-tropic HIV-1 using CCR5 as Drug target yet pharmacological studies have to confirm it.     

Exploring Newer Biosynthetic Gene Clusters in Marine Microbial Prospecting

Marine Biotechnology - Marine microbes genetically evolved to survive varying salinity, temperature, pH, and other stress factors by producing different bioactive metabolites. These microbial...     

生理活性海洋环肽类研究近况

海洋肽类(主要是环肽),由于具有显著的生理活性,引起了人们的很大关注。本文综述了近几年生理活性海洋环肽类的研究概况,包括发现、结构、生理活性等。     

Assessment of the lipid production potential of six benthic diatom species grown in airlift photobioreactors

Journal of Applied Phycology - In recent years diatoms have emerged as a major algal source for the production of bioactive compounds. Marine diatoms grow quickly and can store high amount of...     

海绵微生物生物活性物质的研究进展

海绵独特的摄食、滤食系统使其体内体表富集了大量的微生物,这些微生物能够产生多种结构新颖的生物活性物质,对海绵微生物的研究正在成为开发海洋药物资源的重要内容之一。本文概述了近十年来对海绵微生物生物活性物质的化学成分和生物活性的研究进展。     

海洋细菌活性物质的研究进展

由于海洋细菌有产生多种新颖独特的生物活性物质的巨大潜力,使其成为新药筛选的重要资源,在药品开发研究中具有良好的发展前景。综述了海洋细菌中具有药物开发前景的活性物质的研究和应用现状及其存在的问题。     

First Report of Screening of Novel Angiotensin-I Converting Enzyme Inhibitory Peptides Derived from the Red Alga Acrochaetium sp.

Marine Biotechnology - ACE inhibitors generated from food proteins have recently become the most well-known subclass of bioactive peptides, and their bio-functionality can be a potential...     

群体感应抑制活性海洋细菌的筛选与鉴定

从黄海青岛海域海洋污泥中分离纯化微生物菌株,然后采用紫色色杆菌(Chromobacterium violaceum) 为指示菌株,检测其代谢产物的群体感应(Quorum sensing) 抑制活性,并对具有抑制功能的细菌菌株进行16S rDNA分子鉴定及生理生化特征分析.结果表明,1株蜡样芽孢杆菌和1株水莱茵海默氏菌具有较强的细菌群体感应抑制活性,分别命名为Bacillus cereus QSI01和Rheinheimera aquimaris QSI02.从海洋环境中筛选的具有细菌群体感应抑制活性的菌株,为以致病菌群体感应系统为靶点的新型药物的研发提供了菌种资源.     

Chemoecological study of the invasive alga Caulerpa taxifolia var. distichophylla from the Sicilian coast

Aquatic Ecology - Marine invasive species and their bioactive metabolites have become critical ecological issues in the Mediterranean Sea. In particular, the highly invasive green algae Caulerpa...     

Antioxidant and Antiglycemic Properties of Macroalgae,an Underutilized Blue Economy Bioresource in India

Russian Journal of Marine Biology - Macroalgae are marine bioresources with a myriad of bioactive potential to treat various chronic diseases such as cancer, obesity, diabetes and coronary heart...     

Enteromorpha compressa extract induces anticancer activity through apoptosis and autophagy in oral cancer

Molecular Biology Reports - Marine algae are an auspicious source of innovative bioactive compounds containing possible therapeutic agents against mammalian cancers. However, the mechanism by which...     

Marine drugs--macrolactins

The increasing demands for new lead compounds in pharmaceutical and agrochemical industries have driven scientists to search for new bioactive natural products. Marine microorganisms are rich sources of novel, bioactive secondary metabolites, and have attracted much attention of chemists, pharmacologists, and molecular biologists. This mini-review mainly focuses on macrolactins, a group of 24-membered lactone marine natural products, aiming at giving an overview on their sources, structures, biological activities, as well as their potential medical applications.     

海洋动物来源活性物质的研究新进展

海洋动物因具有产生抗菌物质、抗肿瘤物质、抗病毒物质、免疫调节物质等活性产物的巨大潜力,备受研究人员重视。近年来,各 国研究者已从海洋动物中分离出了数千种结构新颖的活性物质,为新药的开发提供了坚实的基础。简要介绍了近六年来海绵、珊瑚、海参、 海鞘等海洋动物来源的活性物质研究进展,旨在为海洋药用动物资源的开发利用提供参考。     

Marine actinomycetes as a source of novel secondary metabolites

A set of 600 actinomycetes strains which were isolated from marine sediments from various sites in the Pacific and Atlantic Oceans were screened for the production of bioactive secondary metabolites. Marine streptomycete strains were found to be producers of well known chemically diverse antibiotics isolated from terrestrial streptomycetes, as in the case of marine Micromonospora strains. New marine members of the rare genus Verrucosispora seem to be a promising source for novel bioactive secondary metabolites as shown in the case of the abyssomicin producing strain AB-18-032.     

酶法制备海洋活性肽及其功能活性研究进展

海洋生物活性肽(Marine biological active peptide)是从海洋生物中提取的具有优化机体代谢环境、有益于机体健康的一类多肽。酶法制备海洋生物活性肽是目前最常用的制备方法,是通过适当的蛋白酶水解海洋生物蛋白来制备生物活性肽的一种方法。海洋生物活性肽在降血压、抗氧化、抗凝血及抗菌等方面效果显著,对治疗和预防疾病具有巨大潜力。介绍海洋生物活性肽在酶解制备及其生物学功能方面国内外研究进展,为进一步开展海洋活性多肽研究提供参考。     

Biological activities and potential health benefits of bioactive peptides derived from marine organisms

Marine organisms have been recognized as rich sources of bioactive compounds with valuable nutraceutical and pharmaceutical potentials. Recently, marine bioactive peptides have gained much attention because of their numerous health beneficial effects. Notably, these peptides exhibit various biological activities such as antioxidant, anti-hypertensive, anti-human immunodeficiency virus, anti-proliferative, anticoagulant, calcium-binding, anti-obesity and anti-diabetic activities. This review mainly presents biological activities of peptides from marine organisms and emphasizing their potential applications in foods as well as pharmaceutical areas.     

Microbial symbionts of marine invertebrates: opportunities for microbial biotechnology

Marine invertebrates are sources of a diverse array of bioactive metabolites with great potential for development as drugs and research tools. In many cases, microorganisms are known or suspected to be the biosynthetic source of marine invertebrate natural products. The application of molecular microbiology to the study of these relationships will contribute to basic biological knowledge and facilitate biotechnological development of these valuable resources. The bryostatin-producing bryozoan B. neritina and its specific symbiont "Candidatus Endobugula sertula" constitute one promising model system. Another fertile subject for investigation is the listhistid sponges that contain numerous bioactive metabolites, some of which originate from bacterial symbionts.     

Bioactive substances produced by marine isolates of Pseudomonas

Pseudomonas is a genus of non-fermentative gram-negative Gammaproteobacteria found both on land and in the water. Many terrestrial isolates of this genus have been studied extensively. While many produce bioactive substances, enzymes, and biosurfactants, other Pseudomonas isolates are used for biological control of plant diseases and bioremediation. In contrast, only a few marine isolates of this genus have been described that produce novel bioactive substances. The chemical structures of the bioactive substances from marine Pseudomonas are diverse, including pyroles, pseudopeptide pyrrolidinedione, phloroglucinol, phenazine, benzaldehyde, quinoline, quinolone, phenanthren, phthalate, andrimid, moiramides, zafrin and bushrin. Some of these bioactive compounds are antimicrobial agents, and dibutyl phthalate and di-(2-ethylhexyl) phthalate have been reported to be cathepsin B inhibitors. In addition to being heterogeneous in terms of their structures, the antibacterial substances produced by Pseudomonas also have diverse mechanisms of action: some affect the bacterial cell membrane, causing bacterial cell lysis, whereas others act as acetyl-CoA carboxylase and nitrous oxide synthesis inhibitors. Marine Pseudomonas spp. have been isolated from a wide range of marine environments and are a potential untapped source for medically relevant bioactive substances.     

海洋生物材料的研究与应用开发

海洋生物材料的研究与应用开发刘万顺,陈西广（青岛海洋大学海洋生命学院２６６００３）海洋生物材料是指由生物体产生,具有支持细胞结构和机体形态的一类功能性生物大分子。     

Bioactive Natural Products from Papua New Guinea Marine Sponges

The discovery of novel natural products for drug development relies heavily upon a rich biodiversity, of which the marine environment is an obvious example. Marine natural product research has spawned several drugs and many other candidates, some of which are the focus of current clinical trials. The sponge megadiversity of Papua New Guinea is a rich but underexplored source of bioactive natural products. Here, we review some of the many natural products derived from PNG sponges with an emphasis on those with interesting biological activity and, therefore, drug potential. Many bioactive natural products discussed here appear to be derived from non‐ribosomal peptide and polyketide biosynthesis pathways, strongly suggesting a microbial origin of these compounds. With this in mind, we also explore the notion of sponge‐symbiont biosynthesis of these bioactive compounds and present examples to support the working hypothesis.